Botanical species · safety record

Drosera peltata

The EFSA Compendium of Botanicals holds 12 constituent measurements for Drosera peltata. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Drosera peltata Thunb.

12Constituent measurements

0Safety records

7Cited sources

0Licensed products (Canada)

Also recorded as

Drosera peltata var. lunata (Buch.-Ham. ex DC.) C.B.Clarke
Drosera peltata var. multisepala Y.Z.Ruan

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Plumbagin	Aerial part of plants	Solvent extraction	≥ 1.074 Gram/100 gram	—	Resolve DOI
Plumbagin	Aerial part of plants	Solvent extraction	≤ 1.136 Gram/100 gram	—	Resolve DOI
Tannins	Live plants	Solvent extraction	≤ 0.071 Percent	HPLC-DAD	Resolve DOI
Tannins	Live plants	Solvent extraction	≥ 0.031 Percent	HPLC-DAD	Resolve DOI
Droserone	Roots and other underground parts	Solvent extraction	—	—	No resolvable identifier
Droserone	Live plants	—	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Hydroxydroserone	Unspecified	—	—	—	No resolvable identifier
Isoshinanolone	Live plants	—	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Isoshinanolone	—	—	—	—	No resolvable identifier
Naphthoquinones	Aerial part of plants	—	≤ 0.06 Percent	—	No resolvable identifier
Plumbagin	Roots and other underground parts	Solvent extraction	—	—	No resolvable identifier
Plumbagin	Aerial part of plants	—	≤ 33 Percent	—	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Asano, Michizo., Hase, Jun-ichi. Hydroxyquinones. X. Pigment of Drosera peltata. Yakugaku Zasshi, 1943, p. 410-411.
Kolodziej, H., Pertz, H.H., Humke, A. Main constituents of a commercial Drosera fluid extract and their antagonist activity at muscarinic M3 receptors in guinea-pig ileum. Pharmazie, 2002, vol. 57, no. 3, p. 201-203.
Krenn, Liselotte., Laenger, Reinhard., Kopp, Brigitte. Quality control of sundew herb. Part 2. Botanical identification and qualitative and quantitative naphthoquinone determination in commercial samples.. Deutsche Apotheker Zeitung, 1995, p. 41-42.
Tian, Jun., Chen, Yuxin., Ma, Bingxin., He, Jingsheng., Tong, Jing., Wang, Youwei. Drosera peltata Smith var. lunata (Buch.-Ham.) C. B. Clarke as a feasible source of plumbagin: phytochemical analysis and antifungal activity assay. WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY, 2014, vol. 30, no. 2, p. 737-745. DOI
Braunberger, Christina., Zehl, Martin., Conrad, Juergen., Fischer, Sonja., Adhami, Hamid-Reza., Beifuss, Uwe., Krenn, Liselotte. LC-NMR, NMR, and LC-MS identification and LC-DAD quantification of flavonoids and ellagic acid derivatives in Drosera peltata. AND LIFE SCIENCES, 2013, vol. 932, p. 111-116. DOI
Wang, Qiuan., Shu, Jingyu., Zeng, Longmei. A study on chemical constituents of Drosera peltata Smith var. lunata (Buch.-Ham.) C.B. Clarke collected in Tibet. Zhongguo Zhongyao Zazhi, 1998, vol. 23, no. 11, p. 683-704.
Li, Lin., Huang, Jin., Xu, Xianghua., Zhang, Yao., Cheng, Kejun., Yu, Peizhong. [Study on chemical constituents of Drosera peltata var. multisepala].. Chinese materia medica, 2012, vol. 37, no. 2, p. 222-5.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature